Sort
51,593 grants matching “hepatitis”
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway
$725,348Marc R Montminy · Salk Institute For Biological Studies · R01 · FY2022 · DK
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway
$725,348Marc R Montminy · Salk Institute For Biological Studies · R01 · FY2021 · DK
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway
$725,348Marc R Montminy · Salk Institute For Biological Studies · R01 · FY2019 · DK
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors
$725,319Michael Karin · University Of California, San Diego · U01 · FY2021 · AA
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors
$725,319Michael Karin · University Of California, San Diego · U01 · FY2022 · AA
Obesity complicating type 1 diabetes in young people: Physiology and Impact of GLP-1 analogue anti-obesity treatment on cardiometabolic risk factors
$725,290Michelle Van Name · Yale University · R01 · FY2025 · DK
Bay Area Hepatitis C Cooperative Research Center
$725,162James C Ryan · University Of California, San Francisco · U19 · FY2014 · AI
Reducing risk of Anthracycline-related heart failure after childhood cancer
$725,110Saro Armenian · Beckman Research Institute/City Of Hope · R01 · FY2015 · CA
Hepatitis C Pathogenesis and the Human Genome
$725,100David L Thomas · Johns Hopkins University · R01 · FY2009 · DA
Alk1 ligand requirements for AVM prevention in HHT
$725,060Beth L Roman · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL
Multi-Omics Characterization of Plasmodium Vivax Hypnozoites
$725,059David Serre · University Of Maryland Baltimore · R01 · FY2023 · AI
Data-Driven Mathematical and Computational Modeling of Hepatitis D Infection and Treatment Response
$725,051Harel Dahari · Loyola University Chicago · R01 · FY2020 · AI
Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates
$724,972Ryan Eugene Temel · University Of Kentucky · R01 · FY2015 · HL
Ultra-Low Background NIR Fluorophores for In Vivo Imaging and Image-Guided Surger
$724,966John V Frangioni · Beth Israel Deaconess Medical Center · R01 · FY2010 · EB
Stroke with Transfusions Changing to Hydroxyurea (SWITCH) Trial Data Coordinating
$724,948Ronald W. Helms · Rho Federal Systems Division, Inc. · U01 · FY2006 · HL
Gamma Delta T cell and microbial modulation to target chronic SIV-associated inflammation
$724,920Namita Rout · Tulane University Of Louisiana · R01 · FY2023 · DK
A prospective, randomized, clinical trial to evaluate two novel therapies, mycoph
$724,843Timothy Ross Morgan · Southern California Inst For Res/Educ · U01 · FY2013 · AA
Acute HCV Infection in Injection Drug Users
$724,814Brian R. Edlin · Weill Medical Coll Of Cornell Univ · R01 · FY2007 · DA
Delineating the underlying reasons for the racial disparity in gastric cancer incidence in the United States
$724,814Meira Epplein · Duke University · R01 · FY2022 · CA
Effects of aging on primary and secondary vaccine responses in a 15-year longitudinal cohort
$724,766Scott Dexter Boyd · Stanford University · R01 · FY2019 · AI
Role of Factor XII in Thrombo-Inflammatory Complications of Sickle Cell Disease
$724,727Rafal L Pawlinski · Univ Of North Carolina Chapel Hill · R01 · FY2024 · HL
Sensitive Detection of Bacterial Contamination in Platelets
$724,627Season S-S Wong · Lynntech, Inc. · R44 · FY2007 · HL
Exercise Regulation of Glucose Homeostasis
$724,625Laurie J Goodyear · Joslin Diabetes Center · R01 · FY2023 · DK
Molecular signatures for liver cancer diagnosis and treatment stratification
$724,589Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
The role of cancer stem cells in liver cancer heterogeneity and subtypes
$724,589Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA